59 Safety and Tolerability of GWP42006 (Cannabidivarin) in Subjects with Drug Resistant Epilepsy and Autism Spectrum Disorder
G. Barnes L. Sears J. Sullivan

60 Efficacy and Safety of Bumetanide ORAL Liquid Formulation in Children and Adolescents with Autism Spectrum Disorder: Study Protocol of Two Randomised, Double-Blind, Placebo Controlled Phase III Trials
S. Kyaga V. Crutel C. Albarran Y. Ben-Ari D. M. Ravel B. Falissard

61 Family Cognitive-Behavior Therapy for Psychoeducation in Multicenter, Aware and Care for My As Traits for High-Functioning Autism Spectrum Disorders in Adolescence: Study Protocol
Y. Iwama F. Oshima W. Mandy M. Hongo M. Seto Y. Hirano C. Suto M. Kuno J. Takahashi T. Ohtani D. Matsuzawa A. Nakagawa E. Shimizu

62 Feasibility and Design Challenges for a 10-Year Treatment Follow-up Study Examining the LONG-TERM Effects of EARLY Intensive Behavioral Intervention
L. Silverman E. Fischer R. E. King S. Iadarola L. A. Oakes M. Benham T. Smith

63 Preliminary Results of Therapeutic Potential of Multiple Sessional Intermittent Theta Burst Stimulation over the Bilateral Posterior Superior Temporal Sulci in Children and Adolescents with Autism Spectrum Disorder
H. C. Ni H. Y. Lin Y. Z. Huang

64 The Landscape for Recruitment of Pre-School Aged Children with Neurodevelopmental Conditions in Scotland.
E. J. Hutton L. Millar P. Rowe J. Delafield-Butt